Trial Profile
Phase IIB trial of the immunological mechanism of PV 10, an injectable formulation of rose bengal sodium, in patients with malignant melanoma
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 11 Apr 2013
Price :
$35
*
At a glance
- Drugs Rose bengal sodium (Primary)
- Indications Malignant melanoma
- Focus Biomarker; Pharmacodynamics
- 10 Apr 2013 Status changed to discontinued, according to information provided by Provectus Pharmaceuticals.
- 09 Jun 2010 New trial record